SCHEDULE A, Amended and Restated as of April [XX], 2024, to the EXPENSE LIMITATION AGREEMENT, dated October 10, 2023, between THE ADVISORS’ INNER CIRCLE FUND III and RAYLIANT INVESTMENT RESEARCH MAXIMUM ANNUAL OPERATING EXPENSE LIMITS
SCHEDULE A,
Amended and Restated as of April [XX], 2024,
to the
dated October 10, 2023,
between
THE ADVISORS’ INNER CIRCLE FUND III
and
RAYLIANT INVESTMENT RESEARCH
MAXIMUM ANNUAL OPERATING EXPENSE LIMITS
This Agreement relates to the following Funds of the Trust:
| Name of Fund | Maximum Annual Operating Expense Limit | Initial Term End Date |
| Rayliant Quantamental China Equity ETF | 0.80% | January 31, 2025 |
|
Rayliant Quantitative Developed Market Equity ETF |
0.80% | January 31, 2025 |
| Rayliant Quantamental Emerging Market ex-China Equity ETF | 0.88% | January 31, 2025 |
| Rayliant SMDAM Japan Equity ETF | 0.72% | January 31, 2026 |
ACKNOWLEDGED AND ACCEPTED BY:
THE ADVISORS’ INNER CIRCLE FUND III
| By: | ||
| Name: | ||
| Title: |
RAYLIANT INVESTMENT RESEARCH
| By: | ||
| Name: | ||
| Title: |
